Determination of Rates and Reasons for Non-Adherence to Anti-Arrhythmic Therapy for Atrial Fibrillation

Stopped early · Phase 4

Conditions studied: Atrial Fibrillation, Medication Adherence

In brief

The purpose of this study is to determine if follow-up by a pharmacist over the telephone improves adherence and short term clinical outcomes in the patient with atrial fibrillation prescribed an oral anti-arrhythmic medication. This study will also identify the reasons people stop taking their anti-arrhythmic therapy. A pharmacist will provide medication counseling about their anti-arrhythmic therapy, then will follow-up by telephone on a monthly basis to assess adherence over one year.

Key facts

Study ID

NCT01513031

Run by

Creighton University

People needed

9

Starts

2012-01-01

Expected to finish

2012-06-01

Last updated by the study team

2012-07-02

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Prescribed a new anti-arrhythmic medication for atrial fibrillation

Where it is running

• Bryan LGH — Lincoln, Nebraska, United States
• Alegent Health Bergan Mercy Medical Center — Omaha, Nebraska, United States
• Creighton University — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.